4basebio plc (4BB) ORD EUR1
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
1,300.00p
1,310.00p
1,820.00p
£201.21 million
1,300.00p
1,310.00p
520.00p
n/a
0.00p (0.00%) Previous:
0.00p
2
n/a
500
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue (£m) | 0.51 | 0.27 |
| Profit before tax (£m) | (8.35) | (5.93) |
| Adjusted EPS (p): | (0.62) | (0.42) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
4basebio losses widen as it progresses commercial development
27 September 2024 11:24
-
4basebio to provide synthetic DNA to tier-one pharma firm
10 April 2024 11:55
-
4basebio client gets approval to start trial in Australia
21 March 2024 16:11
-
Director's Dealing
19 November 2024 14:15
-
Holding(s) in Company
15 November 2024 17:31
-
Holding(s) in Company
15 November 2024 17:30
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.